Why the study?
Does STK39 variation predict the ambulatory blood pressure response to losartan in hypertensive men?
Does STK39 variation predict the ambulatory blood pressure response to losartan in hypertensive men?
Pharmacogenetic variation in STK39 (rs6749447) predicts a blunted blood pressure response to losartan and is associated with altered renin-angiotensin-aldosterone system activity.
No takes yet. Share an insight, caveat, or question.
May flag losartan hyporesponders; hypothesis-generating and should not yet change practice.
Donner et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: